Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 34 Records) |
| Query Trace: Glioblastoma and CDKN2A[original query] |
|---|
| The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival. PloS one 2011 6 (10): e26737. Royds Janice A, Al Nadaf Shafagh, Wiles Anna K, Chen Yu-Jen, Ahn Antonio, Shaw Alisha, Bowie Sara, Lam Frederic, Baguley Bruce C, Braithwaite Antony W, MacFarlane Martin R, Hung Noelyn A, Slatter Tania |
| EGFR gene variants are associated with specific somatic aberrations in glioma. PloS one 2012 7 (12): 12. Wibom C, Ghasimi S, Van Loo P, Brännström T, Trygg J, Lau C, Henriksson R, Bergenheim T, Andersson U, Rydén P, Melin B |
| Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients. PloS one 2013 8 (6): e65444. Bie?kowski Micha?, Piaskowski Sylwester, Stoczy?ska-Fidelus Ewelina, Szybka Ma?gorzata, Banaszczyk Mateusz, Witusik-Perkowska Monika, Jesie?-Lewandowicz Emilia, Jaskólski Dariusz J, Radomiak-Za?uska Anna, Jesionek-Kupnicka Dorota, Sikorska Beata, Papierz Wielis?aw, Rieske Piotr, Liberski Pawe? |
| H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? Journal of neuro-oncology 2013 Mar 112 (1): 67-72. Gessi Marco, Gielen Gerrit H, Hammes Jennifer, Dörner Evelyn, Mühlen Anja Zur, Waha Andreas, Pietsch Torst |
| Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation. Oncology letters 2015 May 9 (5): 2063-2067. McDonald Kerrie L, Tabone Tania, Nowak Anna K, Erber Wendy |
| Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta neuropathologica 2015 May 129 (5): 669-78. Korshunov Andrey, Ryzhova Marina, Hovestadt Volker, Bender Sebastian, Sturm Dominik, Capper David, Meyer Jochen, Schrimpf Daniel, Kool Marcel, Northcott Paul A, Zheludkova Olga, Milde Till, Witt Olaf, Kulozik Andreas E, Reifenberger Guido, Jabado Nada, Perry Arie, Lichter Peter, von Deimling Andreas, Pfister Stefan M, Jones David T |
| A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution. Cancer research 2015 Nov 75 (22): 4884-94. Walsh Kyle M, de Smith Adam J, Hansen Helen M, Smirnov Ivan V, Gonseth Semira, Endicott Alyson A, Xiao Jianqiao, Rice Terri, Fu Cecilia H, McCoy Lucie S, Lachance Daniel H, Eckel-Passow Jeanette E, Wiencke John K, Jenkins Robert B, Wrensch Margaret R, Ma Xiaomei, Metayer Catherine, Wiemels Joseph |
| Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of neuro-oncology 2016 May 127 (3): 483-92. Ghasimi Soma, Wibom Carl, Dahlin Anna M, Brännström Thomas, Golovleva Irina, Andersson Ulrika, Melin Beatri |
| Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
| Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro-oncology 2017 Jul . Aoki Kosuke, Nakamura Hideo, Suzuki Hiromichi, Matsuo Keitaro, Kataoka Keisuke, Shimamura Teppei, Motomura Kazuya, Ohka Fumiharu, Shiina Satoshi, Yamamoto Takashi, Nagata Yasunobu, Yoshizato Tetsuichi, Mizoguchi Masahiro, Abe Tatsuya, Momii Yasutomo, Muragaki Yoshihiro, Watanabe Reiko, Ito Ichiro, Sanada Masashi, Yajima Hironori, Morita Naoya, Takeuchi Ichiro, Miyano Satoru, Wakabayashi Toshihiko, Ogawa Seishi, Natsume Atsus |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| Comprehensive genetic alteration profiling in primary and recurrent glioblastoma. Journal of neuro-oncology 2018 12 142 (1): 111-118. Neilsen Beth K, Sleightholm Richard, McComb Rodney, Ramkissoon Shakti H, Ross Jeffrey S, Corona Robert J, Miller Vincent A, Cooke Matthew, Aizenberg Michele |
| Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Gene 2018 11 685 85-95. Patil Vikas, Mahalingam Kulandaive |
| TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors. Neuro-oncology advances 2020 7 2 (1): vdz059. Cantero Diana, Mollejo Manuela, Sepúlveda Juan M, D'Haene Nicky, Gutiérrez-Guamán Myriam J, Rodríguez de Lope Ángel, Fiaño Concepción, Castresana Javier S, Lebrun Laetitia, Rey Juan A, Salmon Isabelle, Meléndez Bárbara, Hernández-Laín Aurel |
| TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-oncology advances 2020 11 2 (1): vdaa114. Kikuchi Zensho, Shibahara Ichiyo, Yamaki Tetsu, Yoshioka Ema, Shofuda Tomoko, Ohe Rintaro, Matsuda Ken-Ichiro, Saito Ryuta, Kanamori Masayuki, Kanemura Yonehiro, Kumabe Toshihiro, Tominaga Teiji, Sonoda Yukihi |
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas. Acta neuropathologica communications 2021 7 9 (1): 119. Biczok Annamaria, Strübing Felix L, Eder Julia M, Egensperger Rupert, Schnell Oliver, Zausinger Stefan, Neumann Julia E, Herms Jochen, Tonn Joerg-Christian, Dorostkar Mario |
| The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neuro-oncology advances 2021 6 3 (1): vdab050. Dono Antonio, Ramesh Arvind V, Wang Emily, Shah Mauli, Tandon Nitin, Ballester Leomar Y, Esquenazi Yosh |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. Journal of neuropathology and experimental neurology 2021 4 80 (5): 431-435. Richardson Timothy E, Hatanpaa Kimmo J, Walker Jamie |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma. Neuro-oncology advances 2022 2 4 (1): vdac002. Yang Peter H, Tao Yu, Luo Jingqin, Paturu Mounica, Lu Hsiang-Chih, Ramkissoon Shakti, Heusel Jonathan W, Leuthardt Eric C, Chicoine Michael R, Dowling Joshua L, Dunn Gavin P, Duncavage Eric, Dahiya Sonika, Chattherjee Arindam R, Kim Albert |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
| Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study. Frontiers in oncology 2022 12 12 980059. Pan Rui, Wang Xiaotong, Fang Ru, Xia Qiuyuan, Wu Nan, Rao Q |
| Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
| Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. Journal of neuro-oncology 2022 1 156 (2): 353-363. Dono Antonio, Zhu Ping, Holmes Emma, Takayasu Takeshi, Zhu Jay-Jiguang, Blanco Angel I, Hsu Sigmund, Bhattacharjee Meenakshi B, Ballester Leomar Y, Kim Dong H, Esquenazi Yoshua, Tandon Nit |
| Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor. JCO precision oncology 2022 1 4 575-584. Yan Yuanqing, Takayasu Takeshi, Hines Gabriella, Dono Antonio, Hsu Sigmund H, Zhu Jay-Jiguang, Riascos-Castaneda Roy F, Kamali Arash, Bhattacharjee Meenakshi B, Blanco Angel I, Tandon Nitin, Kim Dong H, Ballester Leomar Y, Esquenazi And Yosh |
| Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A. Neuropathology : official journal of the Japanese Society of Neuropathology 2023 2 . Leske Henning, Blakstad Hanne, Lund-Iversen Marius, Skovholt Else Kathrine, Niehusmann Pitt, Ramm-Pettersen Jon-Terje, Skogen Karoline, Kongelf Geir, Sprauten Mette, Magelssen Henriette, Brandal Pett |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: